Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01725633 · ClinicalTrials.gov registry record · NA
Aerobic Training in Metastatic Breast Cancer
A NA study of Metastatic Breast Cancer, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 27
- Enrollment target
- 2
- Study locations
NCT01725633 is a NA study of Metastatic Breast Cancer that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 27 participants, below the 205-participant average among 139 other Metastatic Breast Cancer trials with a reported enrollment target (87% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT01725633, a NA study of Metastatic Breast Cancer, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study is being done to examine the safety and feasibility of a supervised progressive exercise program in women diagnosed with metastatic breast cancer. Previous research among women with metastatic breast cancer has shown that some of the treatments commonly used in this population may have an adverse impact on physical fitness levels leading to feelings of fatigue and poor quality of life. Supervised exercise training has been shown to reduce some of these side-effects in women with early-stage breast cancer receiving common cancer treatments. However, it is not known if supervised exercise training is a safe and feasible intervention in women with metastatic breast cancer. This study is designed to find out if supervised exercise training is safe as the patients undergo treatments for metastatic breast cancer.
Conditions Studied
Interventions
- OTHER Blood draw
- OTHER Cardiopulmonary Exercise Testing (CPET)
- BEHAVIORAL Nonlinear Aerobic Training
- BEHAVIORAL Progressive Stretching Group
Study Locations (2)
New York
- Memorial Sloan Kettering Cancer Center - New York
North Carolina
- Duke University Medical Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2010-12 |
| Est. Completion | 2023-04-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01725633
The ClinicalTrials.gov registry entry for NCT01725633 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 205-participant average among 139 other Metastatic Breast Cancer trials with a reported enrollment target (87% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Metastatic Breast Cancer appearing as the primary indexed condition, and to 4 interventions - of which Blood draw is the first listed.
NCT01725633 reports 2 study locations spanning 2 distinct geographic areas - top geographies include New York, North Carolina.
Frequently Asked Questions
What is clinical trial NCT01725633 about?
NCT01725633 is a clinical study titled "Aerobic Training in Metastatic Breast Cancer". This study is being done to examine the safety and feasibility of a supervised progressive exercise program in women diagnosed with metastatic breast cancer. Previous research among women with metastatic breast cancer has shown that some of the treatments commonly used in this population may have an...
What is the current status of trial NCT01725633?
This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2010-12. Estimated completion is 2023-04-04.
What conditions does trial NCT01725633 study?
This clinical trial studies the following conditions: Metastatic Breast Cancer.
What interventions are being tested in trial NCT01725633?
The interventions under investigation include: Blood draw (OTHER), Cardiopulmonary Exercise Testing (CPET) (OTHER), Nonlinear Aerobic Training (BEHAVIORAL), Progressive Stretching Group (BEHAVIORAL).
Who is sponsoring clinical trial NCT01725633?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01725633 being conducted?
This trial has 2 study locations across New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Metastatic Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
BettER: Biomarker Driven Early Therapeutic Selection in Patients With HR+ HER2- Metastatic or Unresectable Breast Cancer
RECRUITING · NA
-
Adaptation of a Values Assessment Tool
RECRUITING · NA
-
Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer
RECRUITING · NA
-
Targeted Palliative Care Intervention for Patients With Metastatic Breast Cancer
RECRUITING · NA
-
Feasibility of Symptom Management for Patients With Metastatic Breast Cancer to Increase Exercise
RECRUITING · NA
-
Enhancing Access to Supportive Services for Women of Color With Metastatic Breast Cancer
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.